Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 14 |
---|
Ligand | BDBM50327194 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_664215 (CHEMBL1261656) |
---|
Ki | 433±n/a nM |
---|
Citation | Swann, SL; Merta, PJ; Kifle, L; Groebe, D; Sarris, K; Hajduk, PJ; Sun, C Biochemical and biophysical characterization of unique switch pocket inhibitors of p38a. Bioorg Med Chem Lett20:5787-92 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 14 |
---|
Name: | Mitogen-activated protein kinase 14 |
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 41286.76 |
Organism: | Homo sapiens (Human) |
Description: | Q16539 |
Residue: | 360 |
Sequence: | MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG
TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
|
|
|
BDBM50327194 |
---|
n/a |
---|
Name | BDBM50327194 |
Synonyms: | 5-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)-2-methyl-N-(2-(phenylamino)ethyl)benzamide | CHEMBL1256037 |
Type | Small organic molecule |
Emp. Form. | C34H36N6O2 |
Mol. Mass. | 560.6886 |
SMILES | Cc1ccc(cc1C(=O)NCCNc1ccccc1)-n1nc(cc1NC(=O)Nc1cccc2ccccc12)C(C)(C)C |
Structure |
|